Stone Summit Wealth LLC Invests $2.53 Million in Agilent Technologies, Inc. (NYSE:A)

Stone Summit Wealth LLC acquired a new stake in Agilent Technologies, Inc. (NYSE:A - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 21,630 shares of the medical research company's stock, valued at approximately $2,530,000.

A number of other institutional investors have also recently made changes to their positions in the business. Flynn Zito Capital Management LLC increased its holdings in Agilent Technologies by 3.8% during the 4th quarter. Flynn Zito Capital Management LLC now owns 1,871 shares of the medical research company's stock worth $251,000 after purchasing an additional 69 shares during the period. IFP Advisors Inc grew its position in shares of Agilent Technologies by 17.7% during the fourth quarter. IFP Advisors Inc now owns 458 shares of the medical research company's stock worth $62,000 after buying an additional 69 shares in the last quarter. Tiemann Investment Advisors LLC increased its stake in shares of Agilent Technologies by 5.6% during the fourth quarter. Tiemann Investment Advisors LLC now owns 1,423 shares of the medical research company's stock worth $191,000 after buying an additional 75 shares during the period. Rothschild Investment LLC increased its stake in shares of Agilent Technologies by 19.2% during the fourth quarter. Rothschild Investment LLC now owns 491 shares of the medical research company's stock worth $66,000 after buying an additional 79 shares during the period. Finally, CIBC Private Wealth Group LLC raised its holdings in Agilent Technologies by 1.2% in the fourth quarter. CIBC Private Wealth Group LLC now owns 7,479 shares of the medical research company's stock valued at $1,025,000 after acquiring an additional 87 shares in the last quarter.

Insider Buying and Selling at Agilent Technologies

In other news, Director Daniel K. Podolsky sold 1,819 shares of the firm's stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $116.46, for a total value of $211,840.74. Following the completion of the sale, the director now directly owns 35,737 shares of the company's stock, valued at $4,161,931.02. This trade represents a 4.84% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Agilent Technologies Trading Up 0.9%

NYSE A opened at $119.69 on Friday. The firm's fifty day moving average is $111.85 and its two-hundred day moving average is $124.08. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $153.84. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.60 and a current ratio of 2.09. The firm has a market cap of $34.00 billion, a PE ratio of 29.55, a P/E/G ratio of 3.60 and a beta of 1.23.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings results on Wednesday, May 28th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.26 by $0.05. The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.63 billion. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%. The business's revenue was up 6.0% on a year-over-year basis. During the same quarter last year, the company posted $1.22 earnings per share. Analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 23rd. Investors of record on Tuesday, July 1st will be given a $0.248 dividend. The ex-dividend date is Tuesday, July 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.83%. Agilent Technologies's dividend payout ratio (DPR) is 24.44%.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on A. TD Cowen lifted their price target on Agilent Technologies to $150.00 and gave the stock a "buy" rating in a report on Thursday, May 29th. Wells Fargo & Company decreased their target price on Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating for the company in a research note on Thursday, April 17th. Robert W. Baird lowered their price target on Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating for the company in a report on Thursday, May 22nd. JPMorgan Chase & Co. cut their price objective on shares of Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating on the stock in a report on Thursday, May 29th. Finally, Barclays boosted their price objective on shares of Agilent Technologies from $115.00 to $125.00 and gave the stock an "equal weight" rating in a research report on Tuesday. Eight investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $140.92.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.